Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (101-110 of 748) with videos related to

Pageof 75
Sort By:
Alimentary Pharmacology & Therapeutics|June 25, 2021
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' replyJung Gil Park, Jinho Jung, Rohit Loomba
American Journal of Respiratory and Critical Care Medicine|November 14, 2018
Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver DiseaseOmar A Mesarwi, Rohit Loomba, Atul Malhotra
Alimentary Pharmacology & Therapeutics|May 30, 2024
Monitoring disease progression in metabolic dysfunction-associated steatotic liver diseaseNabil Noureddin, Nedret Copur-Dahi, Rohit Loomba
Alimentary Pharmacology & Therapeutics|May 12, 2026
Editorial: Refining the Natural History of MASLD by Imaging-Based Markers: The GOLDMINE Study. Authors' ReplySuzanne Sharpton, Luis Antonio Diaz, Rohit Loomba
The American Journal of Gastroenterology|June 3, 2016
Editorial: A New Spin on Magnetic Resonance ElastographyRekha Kishore, Rohit Loomba, Richard K Sterling
Hepatology (Baltimore, Md.)|January 12, 2026
Reply: Placebo drift, dose heterogeneity and the winner's curse - re-evaluating the hierarchy of MASH therapeuticsMatheus Souza, Daniel Q Huang, Rohit Loomba
Current Hepatology Reports|November 1, 2016
Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver DiseaseSaumya Jayakumar, Stephen A Harrison, Rohit Loomba
Journal of Hepatology|May 19, 2022
Impact of non-invasive biomarkers on hepatology practice: Past, present and futureQuentin M Anstee, Laurent Castera, Rohit Loomba
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2020
Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challengesKrishna Sriram, Rohit Loomba, Paul A Insel
Radiology|January 16, 2024
Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future DirectionsDiana Kadi, Rohit Loomba, Mustafa R Bashir
Pageof 75

Showing results (101-110 of 748) with videos related to

Sort By:
Pageof 75
Alimentary Pharmacology & Therapeutics|June 25, 2021
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' replyJung Gil Park, Jinho Jung, Rohit Loomba
American Journal of Respiratory and Critical Care Medicine|November 14, 2018
Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver DiseaseOmar A Mesarwi, Rohit Loomba, Atul Malhotra
Alimentary Pharmacology & Therapeutics|May 30, 2024
Monitoring disease progression in metabolic dysfunction-associated steatotic liver diseaseNabil Noureddin, Nedret Copur-Dahi, Rohit Loomba
Alimentary Pharmacology & Therapeutics|May 12, 2026
Editorial: Refining the Natural History of MASLD by Imaging-Based Markers: The GOLDMINE Study. Authors' ReplySuzanne Sharpton, Luis Antonio Diaz, Rohit Loomba
The American Journal of Gastroenterology|June 3, 2016
Editorial: A New Spin on Magnetic Resonance ElastographyRekha Kishore, Rohit Loomba, Richard K Sterling
Hepatology (Baltimore, Md.)|January 12, 2026
Reply: Placebo drift, dose heterogeneity and the winner's curse - re-evaluating the hierarchy of MASH therapeuticsMatheus Souza, Daniel Q Huang, Rohit Loomba
Current Hepatology Reports|November 1, 2016
Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver DiseaseSaumya Jayakumar, Stephen A Harrison, Rohit Loomba
Journal of Hepatology|May 19, 2022
Impact of non-invasive biomarkers on hepatology practice: Past, present and futureQuentin M Anstee, Laurent Castera, Rohit Loomba
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2020
Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challengesKrishna Sriram, Rohit Loomba, Paul A Insel
Radiology|January 16, 2024
Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future DirectionsDiana Kadi, Rohit Loomba, Mustafa R Bashir
Pageof 75